In 2008, Bayer reached a settlement with the U.S. Food & Drug Administration to spend $20 million in advertising to correct the ads for its top-selling contraceptive Yaz. Early ads targeted at women in their 20s and younger promoted the drug as not only for birth control, but also to help cure acne and premenstrual syndrome.
New ads were created, but when they were the Bayer executives that it would be funny to also create a spoof ad for their own internal use callously ignoring the injuries and deaths being attributed to Yaz around the country.
Link to this comment:
All Comments (0)